← Back to all trials
Completed
NCT07103278
A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers
Conditions: Benign Prostatic Hyperplasia
Sex: Male
Ages: 19 Years – N/A
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 44
Sponsor: Addpharma Inc.
Location: H Plus Yangji Hospital Seoul
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Eligibility Criteria
Inclusion Criteria:
* Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
* The Age equal to or greater than 19 in healthy adult male volunteers at the time of screening visit
Exclusion Criteria:
* Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
* Other exclusions applied
Source: ClinicalTrials.gov (NCT07103278). StuddyBuddy aggregates publicly available trial information.
